Page last updated: 2024-11-03

promethazine and Panic Disorder

promethazine has been researched along with Panic Disorder in 1 studies

Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.

Panic Disorder: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.

Research Excerpts

ExcerptRelevanceReference
" Thirty-seven outpatients with panic disorder and agoraphobia (PDA) were treated with imipramine (75-150 mg/day) in an 8-week open, prospective trial."5.09Application of a new statistical approach to evaluate a clinical trial with panic disorder patients. ( Bandelow, B; Beinroth, D; Broocks, A; Brunner, E; Hajak, G; Pralle, L; Rüther, E, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bandelow, B1
Brunner, E1
Beinroth, D1
Pralle, L1
Broocks, A1
Hajak, G1
Rüther, E1

Trials

1 trial available for promethazine and Panic Disorder

ArticleYear
Application of a new statistical approach to evaluate a clinical trial with panic disorder patients.
    European archives of psychiatry and clinical neuroscience, 1999, Volume: 249, Issue:1

    Topics: Adult; Agoraphobia; Clinical Trials as Topic; Desensitization, Psychologic; Female; Humans; Imiprami

1999